| Literature DB >> 26862546 |
Ali Shahrami1, Mehdi Norouzi1, Hamid Kariman1, Hamid Reza Hatamabadi1, Ali Arhami Dolatabadi1.
Abstract
INTRODUCTION: Vertigo prevalence is estimated to be 1.8% among young adults and more than 30% in the elderly. 13-38% of the referrals of patients over 65 years old in America are due to vertigo. Vertigo does not increase the risk of mortality but it can affect the patient's quality of life. Therefore, this study was designed to evaluate the epidemiologic characteristics of vertigo patients referred to the emergency department (ED).Entities:
Keywords: Vertigo; emergency department; epidemiology; mass screening
Year: 2016 PMID: 26862546 PMCID: PMC4744610
Source DB: PubMed Journal: Emerg (Tehran) ISSN: 2345-4563
Baseline characteristic of the studied patients
|
|
|
|---|---|
|
| |
| Female | 220 (58.13) |
| Male | 159 (41.86) |
|
| |
| Under 40 | 72 (18.99) |
| 40-50 | 111 (29.28) |
| 50-60 | 140 (36.93) |
| Over 60 | 56 (14.77) |
|
| |
| 4 and 5 | 87 (17.68) |
| 3 | 405 (82.13) |
|
| |
| Hypertension | 78 (20) |
| Diabetes | 33 (8.7) |
| Seizure | 3 (0.7) |
| head trauma | 4 (1) |
| Multiple sclerosis | 1 (0.2) |
| Vertigo | 28 (7) |
|
| |
| Nausea and vomiting | 335 (88.39) |
| Tinnitus | 31 (8.17) |
| Headache | 14 (3.69) |
| Hearing loss | 2 (0.52) |
|
| |
| Normal | 366 (96.54) |
| Abnormal | 13 (3.43) |
|
| |
| With indication | 173 (80.09) |
| Without indication | 43 (19.90) |
| MRI | |
| With indication | 14 (36.84) |
| Without indication | 24 (63.16) |
|
| |
| Internal neurology service | 68 (17.9) |
| Neurosurgery service | 2 (0.5) |
Base on emergency severity index (ESI) triage system.
Computed tomography (CT) scan indications: age over 55, Abnormal neurologic findings, history of diabetes and hypertension.
Magnetic resonance imaging (MRI) indications: abnormal cerebellar tests and history of multiple sclerosis.
Figure1Frequency of central and peripheral vertigo based on age groups (p < 0.001). Data are presented as frequency in this figure.
Correlation between the results of history and clinical examination and final decision of central or peripheral vertigo
|
|
|
| |
|---|---|---|---|
|
|
| ||
|
| 4 (1.2) | 331 (98.8) | < 0.001 |
|
| 0 (0.0) | 2 (100.0) | 0.93 |
|
| 0 (0.0) | 100 (100.0) | 0.32 |
|
| 0 (0.0) | 28 (100.0) | 0.36 |
|
| 1 (25.0) | 3 (75.0) | 0. 13 |
|
| 2 (14.3) | 12 (85.7) | 0.08 |
|
| 0 (0.0) | 3 (100.0) | 0.90 |
|
| 4 (12.1) | 29 (87.9) | 0.02 |
|
| 8 (10.3) | 70 (89.7) | < 0.001 |
Most common treatment regimens prescribed for patients
|
|
|
|---|---|
| Promethazine-ondansetron | 96 (25.3) |
| Promethazine-metoclopramide | 71 (18.7) |
| Diazepam-ondansetron | 83 (21.9) |
| Diazepam-metoclopramide | 59 (15.6) |
| Promethazine | 45 (11.9) |
| Ondansetron | 16 (4.2) |
| Diazepam | 9 (2.4) |
Screening performance characteristics of history and clinical examination in differentiating central and peripheral vertigo
| Screening characteristics | (95% Confidence Interval) |
|---|---|
|
| 90 (57-99) |
|
| 99 (97-99) |
|
| 76 (49-93) |
|
| 99 (98-99) |
|
| 3.3 (1.9-9.4) |
|
| 0.002 (0.0003-0.01) |